<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Bio-Reference Laboratories Inc</title>
	<atom:link href="http://www.stockbloghub.com/tag/bio-reference-laboratories-inc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Mon, 21 May 2012 16:42:30 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(DGX) Why Healthcare Reform Should Help The Diagnostics Industry</title>
		<link>http://www.stockbloghub.com/2010/04/01/dgx-why-healthcare-reform-should-help-the-diagnostics-industry/32633</link>
		<comments>http://www.stockbloghub.com/2010/04/01/dgx-why-healthcare-reform-should-help-the-diagnostics-industry/32633#comments</comments>
		<pubDate>Thu, 01 Apr 2010 21:37:50 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[Bio-Reference Laboratories Inc]]></category>
		<category><![CDATA[BRLI]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Genomic Health Inc.]]></category>
		<category><![CDATA[Genoptix]]></category>
		<category><![CDATA[GHDX]]></category>
		<category><![CDATA[GXDX]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=32633</guid>
		<description><![CDATA[America seems to be divided into two camps… Not blue states versus red states. Not Yankees fans versus Red Sox fans (although why you’d be the latter I’ll never understand). Not even people who support the new healthcare reform bill versus those who are opposed to it. Rather, I’m talking about the difference between people who run to the doctor for every little ache and pain, compared with those who wouldn’t go within 50 yards of a doctor’s office even if their internal organs suddenly became external… The Diagnostics Industry: More Healthcare Coverage Means More Business My family and I try to stay out of doctor’s offices. This has been the case, ever since a routine visit to get my six-year-old son some orthopedics in his shoes turned into scheduled ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/01/dgx-why-healthcare-reform-should-help-the-diagnostics-industry/32633/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BRLI) Bio-Reference Labs &#8211; Analysts React By Raising Estimates</title>
		<link>http://www.stockbloghub.com/2010/03/29/brli-bio-reference-labs-analysts-react-by-raising-estimates/32105</link>
		<comments>http://www.stockbloghub.com/2010/03/29/brli-bio-reference-labs-analysts-react-by-raising-estimates/32105#comments</comments>
		<pubDate>Mon, 29 Mar 2010 16:45:07 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[Bio-Reference Laboratories Inc]]></category>
		<category><![CDATA[BRLI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=32105</guid>
		<description><![CDATA[Bio-Reference Labs (BRLI) recently beat earnings estimates once again. Shares are up roughly 10% since being featured as a Zacks Rank Buy in December. Company Description Bio-Reference Laboratories, provides clinical laboratory testing services such as blood and urine analysis in the New York metropolitan area. The company was founded in 1981 and has a market cap of $536 million. Another Surprise On Mar 4 Bio-Reference reported first-quarter results that included a 31% jump in revenue. The growth came on over patient growth as well as revenue per patient. Earnings per shares came in at 29 cents, 6 cents ahead of expectations. Bio-Referance has now topped estimates 7 times in a row. Analysts React Bio-Reference analysts raised their estimates following the news. The Zacks Consensus Estimate for fiscal 2010 is up ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/29/brli-bio-reference-labs-analysts-react-by-raising-estimates/32105/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BRLI) Bio-Reference Labs &#8211; Earnings Estimates Are Rising</title>
		<link>http://www.stockbloghub.com/2009/12/30/brli-bio-reference-labs-earnings-estimates-are-rising/23896</link>
		<comments>http://www.stockbloghub.com/2009/12/30/brli-bio-reference-labs-earnings-estimates-are-rising/23896#comments</comments>
		<pubDate>Wed, 30 Dec 2009 21:54:14 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[Bio-Reference Laboratories Inc]]></category>
		<category><![CDATA[BRLI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=23896</guid>
		<description><![CDATA[Bio-Reference Laboratories (BRLI) is setting new 52-week highs following its record-breaking quarter. Company Description Bio-Referance Laboratories, provides clinical laboratory testing services such as blood and urine analysis in the New York metropolitan area. The company was founded in 1981 and has a market cap of $536 million. Record-Setting Quarter On Dec 17 the company reported fourth-quarter revenue of $102 million, Bio-Referance&#8217;s highest to date. In the same period last year revenue was $81 million, making this a 26% increase. Net income was up 37%, to $7.2 million. Earnings per share were 51 cents, 7 cents higher than the Zacks Consensus Estimate, making it the sixth consecutive earnings surprise. Sustainable Growth In the same press release, Marc D. Grodman, MD, CEO, said &#8220;All aspects of our business have seen growth over ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/30/brli-bio-reference-labs-earnings-estimates-are-rising/23896/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BRLI) Bio-Reference Laboratories Inc. &#8211; In spite of the weak economy, revenue was up 16% from last year</title>
		<link>http://www.stockbloghub.com/2009/07/23/brli-bio-referance-laboratories-inc-in-spite-of-the-weak-economy-revenue-was-up-16-from-last-year/11136</link>
		<comments>http://www.stockbloghub.com/2009/07/23/brli-bio-referance-laboratories-inc-in-spite-of-the-weak-economy-revenue-was-up-16-from-last-year/11136#comments</comments>
		<pubDate>Thu, 23 Jul 2009 18:53:54 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[Bio-Reference Laboratories Inc]]></category>
		<category><![CDATA[BRLI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=11136</guid>
		<description><![CDATA[Bio-Reference Laboratories Inc. (BRLI) is posting impressive gains in response to strong revenue growth and expanding margins. Company Description Bio-Reference Laboratories, provides clinical laboratory testing services such as blood and urine analysis in the New York metropolitan area. The company was founded in 1981 and has a market cap of $436 million. Shares of BRLI began rallying in early March with the overall market, but received a nice boost on June 4 when the company reported strong second-quarter results. Second-Quarter Results In spite of the weak economy, revenue was up 16% from last year to $87.2 million, a company record. Earnings came in at 33 cents per share, besting the consensus of 28 cents. Details Bio-Reference gained in a number of key statistical categories, posting a 17% improvement in gross ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/07/23/brli-bio-referance-laboratories-inc-in-spite-of-the-weak-economy-revenue-was-up-16-from-last-year/11136/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ATK) Zacks #1 Rank Additions for Monday  &#8211; Zacks Tale of the Tape</title>
		<link>http://www.stockbloghub.com/2009/06/08/atk-zacks-1-rank-additions-for-monday-zacks-tale-of-the-tape/8013</link>
		<comments>http://www.stockbloghub.com/2009/06/08/atk-zacks-1-rank-additions-for-monday-zacks-tale-of-the-tape/8013#comments</comments>
		<pubDate>Mon, 08 Jun 2009 22:08:08 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Aerospace/Defense Products & Services]]></category>
		<category><![CDATA[Industrial Goods]]></category>
		<category><![CDATA[AFG]]></category>
		<category><![CDATA[Alliant Techsystems Inc.]]></category>
		<category><![CDATA[American Financial Group Inc.]]></category>
		<category><![CDATA[American Technology Corp.]]></category>
		<category><![CDATA[ATCO]]></category>
		<category><![CDATA[ATK]]></category>
		<category><![CDATA[Bio-Reference Laboratories Inc]]></category>
		<category><![CDATA[BRLI]]></category>
		<category><![CDATA[Cantel Medical Corp]]></category>
		<category><![CDATA[CapLease]]></category>
		<category><![CDATA[Check Point Software Technolog]]></category>
		<category><![CDATA[CHKP]]></category>
		<category><![CDATA[CMN]]></category>
		<category><![CDATA[G-III Apparel Group]]></category>
		<category><![CDATA[GIII]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[Inc.]]></category>
		<category><![CDATA[LSE]]></category>
		<category><![CDATA[LTD]]></category>
		<category><![CDATA[Merge Healthcare Incorporated.]]></category>
		<category><![CDATA[MRGE]]></category>
		<category><![CDATA[Orchids Paper Products Company]]></category>
		<category><![CDATA[Phillips-Van Heusen Corp.]]></category>
		<category><![CDATA[PVH]]></category>
		<category><![CDATA[Raven Industries Inc.]]></category>
		<category><![CDATA[RAVN]]></category>
		<category><![CDATA[Ross Stores Inc.]]></category>
		<category><![CDATA[ROST]]></category>
		<category><![CDATA[Smart Balance]]></category>
		<category><![CDATA[SMBL]]></category>
		<category><![CDATA[TIS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=8013</guid>
		<description><![CDATA[Here are the stocks added to the Zacks #1 Rank (&#8220;strong buy&#8221;) List today: Alliant Techsystems Inc (ATK) American Financial Group (AFG) American Technology Corp (ATCO) Associated British Foods Plc (ASBFY) Bio-Reference Laboratories Inc (BRLI) Cantel Medical Corp (CMN) CapLease Inc (LSE) Check Point Software Technologies Ltd (CHKP) Forest Oil Corp (FST) G-III Apparel Group Ltd (GIII) Goldman Sachs Group Inc (GS) Henkel AG And Co KG (HENKY) Keppel Corporation Ltd (KPELY) Merge Healthcare Inc (MRGE) Orchids Paper Products Co (TIS) PennantPark Investment Corp (PNNT) Phillips-Van Heusen Corp (PVH) Raven Industries Inc (RAVN) Ross Stores Inc (ROST) Smart Balance Inc (SMBL) Tutor Perini Corp (TPC) Wal-mart de Mexico SAB de CV (WMMVY) Zacks Investment Research View original at: Zacks.com News Feed]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/06/08/atk-zacks-1-rank-additions-for-monday-zacks-tale-of-the-tape/8013/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BRLI) Bio-Reference Laboratories &#8211; This was the second consecutive quarter that the company has surprised and beat estimates</title>
		<link>http://www.stockbloghub.com/2008/12/26/brli-bio-reference-laboratories-this-was-the-second-consecutive-quarter-that-the-company-has-surprised-and-beat-estimates/1860</link>
		<comments>http://www.stockbloghub.com/2008/12/26/brli-bio-reference-laboratories-this-was-the-second-consecutive-quarter-that-the-company-has-surprised-and-beat-estimates/1860#comments</comments>
		<pubDate>Fri, 26 Dec 2008 23:49:19 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[Bio-Reference Laboratories Inc]]></category>
		<category><![CDATA[BRLI]]></category>
		<category><![CDATA[VitalStocks]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=1860</guid>
		<description><![CDATA[Bio-Reference Laboratories, Inc. (BRLI) share price has been rallying since the company reported excellent fourth-quarter and full-year results last week. The next-year estimate has held steady, pegged at $1.48 per share, a n 8.5% earnings growth projection. Company Description Bio-Reference Laboratories, Inc. provides clinical laboratory testing services primarily in the greater New York metropolitan area. The company was founded in 1981 and has a market cap of $364 million. Fourth-Quarter Results Bio-Ref Labs chimed-in with impressive fourth-quarter and year-end results on Dec 18. Revenue for the quarter was up 16% from last year to $81.2 million. Income came in at $5.2 million, up from $4.6 million last year. This produced earnings of 38 cents per share, ahead of estimates by 2 cents. This was the second consecutive quarter that the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/12/26/brli-bio-reference-laboratories-this-was-the-second-consecutive-quarter-that-the-company-has-surprised-and-beat-estimates/1860/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

